Award
National Cancer Institute 5R01CA248381-05
Leveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid Leukemia
Recipient
Not specified
Award Amount
$351,576.00
Ceiling
$351,576.00
Awarded
July 10, 2025
Identifier
5R01CA248381-05
Research project funded by the National Cancer Institute to identify target neoantigens in FLT3-ITD positive Acute Myeloid Leukemia using TCR repertoire analysis, aiming to develop personalized treatments and engineered T cell therapies.
Description
This project involves research on neoantigens in AML, TCR repertoire analysis, and immunogenomics. It is funded by the NIH/NCI under grant PA-19-056. The project aims to develop personalized treatments and engineered T cell therapies.